Navigation Links
U.S. Officials Take Aim at Questionable STD Products
Date:5/3/2011

TUESDAY, May 3 (HealthDay News) -- The U.S. Food and Drug Administration and the U.S. Federal Trade Commission are cracking down on manufacturers of over-the-counter products that claim to treat, cure or prevent sexually transmitted diseases.

The agencies jointly sent letters to companies including Medavir, Herpaflor, Viruxo, C-Cure and Never An Outbreak, warning that their products are unproven and violate federal law, the FDA said in a news release issued Tuesday.

"These products are dangerous because they are targeted to patients with serious conditions, where treatment options proven to be safe and effective are available," Deborah M. Autor, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research, said in the release.

Chlamydia, genital warts, herpes, HIV and AIDS are among the diseases that the products -- sold online and through retail outlets -- claim to treat. However, the only FDA-approved medications available to treat these conditions require a prescription and supervision of a health-care professional, the agency said.

Because the products have not been evaluated for safety and effectiveness, people who buy them may not get needed treatment and could then infect their sexual partners, Autor said.

The items are considered drug products under the Federal Food, Drug, and Cosmetic Act because they are sold to treat disease, and they violate interstate commerce law if they lack an FDA-approved new drug application, the FDA explained. Further, under the Federal Trade Commission Act it is illegal to make unsubstantiated treatment claims, regulators said.

"These companies are on notice that advertising health benefits that are not supported by rigorous scientific evidence violates the FTC Act," said David Vladeck, director of the FTC's Bureau of Consumer Protection. Health scams that endanger public health will not be tolerated, he added.

The letters are the first step in removing the unproven products from the market. The companies have 15 days to inform the FDA of measures they're taking to correct the alleged violations or face possible legal action.

More information

The U.S. National Library of Medicine has more about sexually transmitted diseases.

-- HealthDay staff

SOURCE: U.S. Food and Drug Administration, news release, May 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Online Tool Created to Contact Vatican Officials: Why Are American Bishops Allowed to Defy the Popes Words Concerning Child Killing and the Eucharist?
2. Officials See Uptick in H1N1 Swine Flu Cases
3. Infant Sleep Positioners Dangerous, U.S. Health Officials Warn
4. U.S. Officials Recommend Reduced Fluoride Levels in Water
5. LearnSomething Brings Phil Keough On Board to Spearhead Retail Products and Services
6. Health & Sports: Former NBA Star John Salley Endorses STEMTech Stem Cell Nutrition Products
7. For a Healthier, Cleaner Fitness Regimen - Venture Products Shock Athletic(TM) Mats and Interlocking Flooring
8. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
9. Summit VetPharm Enters Agreement With MWI Veterinary Supply to Distribute Vectra(R) Products
10. GNC Announces Entry to Chinas Nutritional Products in Partnership with Bright Food
11. First Coast Service Options (FCSO) Expands Use of Burgess Products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Officials Take Aim at Questionable STD Products 
(Date:2/17/2017)... Ocala, FL (PRWEB) , ... February 17, 2017 ... ... of software tools that allow for the electronic prescribing of controlled and non-controlled ... , Ninety percent of pharmacies in the United States now accept electronic ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Carol Francis' goals for each and every seminar, session and class she ... demonstrate five different brainwave tools which help energize creativity, focus mental functions, enhance ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today announced that ... Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will be the ... patient signatures solution in healthcare . , Since it first introduced Electronic ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across ... Driven in large part by the Hospital Readmission Reduction Program (HRRP), the return of ... focus area for hospitals across the nation. While many providers are struggling to leverage ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 2017  Express Scripts (NASDAQ: ESRX ) was recognized ... Companies within the Health Care: Pharmacy and Other Services category. ... World,s Most Admired Companies," said Tim Wentworth , CEO and ... passion of our 26,000 employees to make medicine more affordable and ... ...
(Date:2/16/2017)...  Prescription pain medications provided by "physicians in the ... long-term opioid use to take hold," according to a ... of The New England Journal of Medicine ... in acute pain than in almost any other medical ... of the American College of Emergency Physicians. "The challenge ...
(Date:2/16/2017)... , Feb. 16, 2017   Spectralink ... solutions for the healthcare, retail, manufacturing and hospitality ... on the performance and symbology support features of ... a dual-mode camera/barcode scanner. The study, conducted by ... the PIVOT:SC to two phones with dedicated hardware ...
Breaking Medicine Technology: